AUPQ656500A0 - A method of treatment and agents for same - Google Patents

A method of treatment and agents for same

Info

Publication number
AUPQ656500A0
AUPQ656500A0 AUPQ6565A AUPQ656500A AUPQ656500A0 AU PQ656500 A0 AUPQ656500 A0 AU PQ656500A0 AU PQ6565 A AUPQ6565 A AU PQ6565A AU PQ656500 A AUPQ656500 A AU PQ656500A AU PQ656500 A0 AUPQ656500 A0 AU PQ656500A0
Authority
AU
Australia
Prior art keywords
agents
treatment
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPQ6565A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AUTOGEN Pty Ltd
Original Assignee
AUTOGEN Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AUTOGEN Pty Ltd filed Critical AUTOGEN Pty Ltd
Priority to AUPQ6565A priority Critical patent/AUPQ656500A0/en
Publication of AUPQ656500A0 publication Critical patent/AUPQ656500A0/en
Priority to PCT/AU2001/000348 priority patent/WO2001072320A1/en
Priority to AU2001243938A priority patent/AU2001243938A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AUPQ6565A 2000-03-28 2000-03-28 A method of treatment and agents for same Abandoned AUPQ656500A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPQ6565A AUPQ656500A0 (en) 2000-03-28 2000-03-28 A method of treatment and agents for same
PCT/AU2001/000348 WO2001072320A1 (en) 2000-03-28 2001-03-28 A method of treatment of metabolic disorders and agents useful for same
AU2001243938A AU2001243938A1 (en) 2000-03-28 2001-03-28 A method of treatment of metabolic disorders and agents useful for same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPQ6565A AUPQ656500A0 (en) 2000-03-28 2000-03-28 A method of treatment and agents for same

Publications (1)

Publication Number Publication Date
AUPQ656500A0 true AUPQ656500A0 (en) 2000-04-20

Family

ID=3820661

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPQ6565A Abandoned AUPQ656500A0 (en) 2000-03-28 2000-03-28 A method of treatment and agents for same

Country Status (2)

Country Link
AU (1) AUPQ656500A0 (en)
WO (1) WO2001072320A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2962041B1 (en) * 2010-07-01 2012-07-27 Genethon INHIBITORS OF CALPAIN 3 FOR THE TREATMENT OF MUSCULAR DYSTROPHIES AND CARDIOMYOPATHIES

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340922B1 (en) * 1988-05-31 1999-11-02 Mclean Hospital Corp Neural calcium-activated neutral proteinase inhibitors
JP2866151B2 (en) * 1990-05-18 1999-03-08 寳酒造株式会社 Method and kit for detecting calpastatin abnormality
US5607831A (en) * 1993-03-25 1997-03-04 The United States Of America As Represented By The Department Of Health And Human Services In vitro methods for assessing the susceptibility of HIV-1-infected individuals to cysteine protease-mediated activation-induced programmed cell death
US5536639A (en) * 1994-03-25 1996-07-16 Cephalon, Inc. Methods for detecting calpain activation by detection of calpain activated spectrin breakdown products
CN1245536A (en) * 1996-12-04 2000-02-23 Basf公司 Novel calpaines, production and use thereof
DE19737105A1 (en) * 1997-08-26 1999-03-04 Basf Ag New tissue-specific calpains, their production and use
AU756370B2 (en) * 1998-07-17 2003-01-09 Licentia Ltd Myotilin, an actin-organizing protein
WO2000021550A2 (en) * 1998-10-13 2000-04-20 President And Fellows Of Harvard College Methods and compositions for treating neurodegenerative diseases
WO2001018216A2 (en) * 1999-09-09 2001-03-15 Millennium Pharmaceuticals, Inc. 26176, a novel calpain protease and uses thereof

Also Published As

Publication number Publication date
WO2001072320A1 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
AU2002215261A1 (en) Method and arrangement for treatment of fluid
AU2002223275A1 (en) A method of expression and agents identified thereby
AU2001286983A1 (en) Method of treatment
EP1113808A4 (en) A method of treatment and agents useful for same
AUPQ582400A0 (en) A method of treatment and agents for use therein
AUPQ592100A0 (en) A method of treatment and prophylaxis
AU2001262177A1 (en) Method of treatment
AU2002362181A1 (en) Arrangement and method for treatment of a pumpable substance
AU2002225241A1 (en) A device and method for treating the skin of a subject
AUPQ614700A0 (en) A method and agents useful for same
AUPQ199999A0 (en) A method of treatment and agents useful for same
EP1267911A4 (en) A method of treatment
AUPQ656500A0 (en) A method of treatment and agents for same
AU781936C (en) A method of treatment and agents useful for same
AUPQ800300A0 (en) A method of treatment and agents useful for same
AUPQ645500A0 (en) A method of treatment and agents useful for same
AUPQ065299A0 (en) A method of prophylaxis and treatment and agents useful for same
AUPR845601A0 (en) A method of treatment and agents useful for same
AUPR552101A0 (en) A method of treatment and agents useful for same
AU2002231465A1 (en) A method of treatment and agents useful for same
AUPR329901A0 (en) A method of treatment and agents useful for same
AUPR752801A0 (en) A method of treatment and agents useful for same
AUPQ124899A0 (en) A method of treatment and agents useful for same
AUPP865899A0 (en) A method of treatment and agents useful for same
AUPR975901A0 (en) A method of treatment and agents useful for same - III

Legal Events

Date Code Title Description
NAA1 Application designating australia and claiming priority from australian document

Ref document number: 4393801

Country of ref document: AU